Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

NASDAQ:XMTR - Nasdaq - US98423F1093 - Common Stock - Currency: USD

22.18  +0.14 (+0.64%)

After market: 22.18 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XMTR. XMTR was compared to 48 industry peers in the Trading Companies & Distributors industry. XMTR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, XMTR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XMTR has reported negative net income.
In the past year XMTR has reported a negative cash flow from operations.
In the past 5 years XMTR always reported negative net income.
XMTR had a negative operating cash flow in each of the past 5 years.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of XMTR (-7.41%) is worse than 91.67% of its industry peers.
XMTR has a worse Return On Equity (-16.03%) than 89.58% of its industry peers.
Industry RankSector Rank
ROA -7.41%
ROE -16.03%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

XMTR's Gross Margin of 39.53% is fine compared to the rest of the industry. XMTR outperforms 68.75% of its industry peers.
In the last couple of years the Gross Margin of XMTR has grown nicely.
The Profit Margin and Operating Margin are not available for XMTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XMTR has more shares outstanding
The number of shares outstanding for XMTR has been increased compared to 5 years ago.
Compared to 1 year ago, XMTR has a worse debt to assets ratio.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.03 indicates that XMTR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.03, XMTR is doing worse than 64.58% of the companies in the same industry.
A Debt/Equity ratio of 0.90 indicates that XMTR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.90, XMTR perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 2.03
ROIC/WACCN/A
WACC8.9%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 4.38 indicates that XMTR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.38, XMTR belongs to the best of the industry, outperforming 89.58% of the companies in the same industry.
A Quick Ratio of 4.33 indicates that XMTR has no problem at all paying its short term obligations.
XMTR has a better Quick ratio (4.33) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.38
Quick Ratio 4.33
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

6

3. Growth

3.1 Past

XMTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.50%, which is quite impressive.
The Revenue has grown by 17.74% in the past year. This is quite good.
The Revenue has been growing by 46.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)17.74%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%15.92%

3.2 Future

Based on estimates for the next years, XMTR will show a very strong growth in Earnings Per Share. The EPS will grow by 188.58% on average per year.
Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 17.24% on average per year.
EPS Next Y675.73%
EPS Next 2Y285.68%
EPS Next 3Y188.58%
EPS Next 5YN/A
Revenue Next Year19.11%
Revenue Next 2Y18.19%
Revenue Next 3Y17.4%
Revenue Next 5Y17.24%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XMTR. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 77.05, XMTR can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, XMTR is valued a bit more expensive than the industry average as 72.92% of the companies are valued more cheaply.
XMTR is valuated expensively when we compare the Price/Forward Earnings ratio to 20.85, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 77.05
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XMTR's earnings are expected to grow with 188.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y285.68%
EPS Next 3Y188.58%

More info and screens

0

5. Dividend

5.1 Amount

XMTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOMETRY INC-A

NASDAQ:XMTR (4/21/2025, 8:00:02 PM)

After market: 22.18 0 (0%)

22.18

+0.14 (+0.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners95.19%
Inst Owner Change0.23%
Ins Owners6.23%
Ins Owner Change11.19%
Market Cap1.12B
Analysts80
Price Target36.21 (63.26%)
Short Float %8.69%
Short Ratio5.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)142.65%
Min EPS beat(2)100.56%
Max EPS beat(2)184.74%
EPS beat(4)4
Avg EPS beat(4)97.38%
Min EPS beat(4)12.07%
Max EPS beat(4)184.74%
EPS beat(8)8
Avg EPS beat(8)62.96%
EPS beat(12)11
Avg EPS beat(12)49.28%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.19%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.05%
Revenue beat(8)4
Avg Revenue beat(8)-0.24%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.93%
PT rev (3m)9.57%
EPS NQ rev (1m)25%
EPS NQ rev (3m)-113.71%
EPS NY rev (1m)-3.51%
EPS NY rev (3m)3.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.56%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 77.05
P/S 2.05
P/FCF N/A
P/OCF N/A
P/B 3.55
P/tB 56.84
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.29
Fwd EY1.3%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS10.85
BVpS6.25
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.41%
ROE -16.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.53%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139.08%
Cap/Sales 3.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.38
Quick Ratio 4.33
Altman-Z 2.03
F-Score5
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next Y675.73%
EPS Next 2Y285.68%
EPS Next 3Y188.58%
EPS Next 5YN/A
Revenue 1Y (TTM)17.74%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%15.92%
Revenue Next Year19.11%
Revenue Next 2Y18.19%
Revenue Next 3Y17.4%
Revenue Next 5Y17.24%
EBIT growth 1Y23.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.35%
EBIT Next 3Y86.72%
EBIT Next 5Y64.67%
FCF growth 1Y30.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.51%
OCF growth 3YN/A
OCF growth 5YN/A